Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Clinical Investigation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI112772PMID 3025256PMCID PMC424004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Participation of endothelial cells in the protein C-protein S anticoagulant pathway: the synthesis and release of protein S

  1986cited by this paper
• Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.

  1986cited by this paper
• The effect of bovine thrombomodulin on the specificity of bovine thrombin.

  1986cited by this paper
• Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.

  1986cited by this paper
• Modulation of endothelial cell hemostatic properties by tumor necrosis factor

  1986cited by this paper
• Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.

  1986cited by this paper
• Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture.

  1985cited by this paper
• Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.

  1985cited by this paper
• Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin.

  1985cited by this paper
• The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X.

  1985cited by this paper
• In vitro detection of endothelial cell damage using 2-deoxy-D-3H-glucose: comparison with chromium 51, 3H-leucine, 3H-adenine, and lactate dehydrogenase.

  1985cited by this paper
• The effect of serum on monocyte tissue factor generation.

  1984cited by this paper
• Familial protein S deficiency is associated with recurrent thrombosis.

  1984cited by this paper
• Clinical Studies of Protein C

  1984cited by this paper
• Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V.

  1984cited by this paper
• Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.

  1984cited by this paper
• Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets

  1984cited by this paper
• Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells

  1984cited by this paper
• ROLE OF VON WILLEBRAND FACTOR IN PLATELET ADHESION TO THE SUBENDOTHELIUM

  1983cited by this paper
• Binding of factors IX and IXa to cultured vascular endothelial cells.

  1983cited by this paper
• Inactivation of human coagulation factor V by activated protein C.

  1983cited by this paper
• Cellular cooperation in endothelial cell thromboplastin synthesis

  1983cited by this paper
• Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C.

  1983cited by this paper
• Cultured human endothelial cells generate tissue factor in response to endotoxin.

  1983cited by this paper
• Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.

  1983cited by this paper
• Effects of lipopolysaccharide on human endothelial cells in culture.

  1983cited by this paper
• Cultured bovine endothelial cells produce both urokinase and tissue- type plasminogen activators

  1982cited by this paper
• Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation.

  1982cited by this paper
• Deleterious effects of endotoxin on cultured endothelial cells: An in vitro model of vascular injury

  1981cited by this paper
• Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment.

  1981cited by this paper
• Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

  1981cited by this paper
• Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

  1981cited by this paper
• Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia.

  1981cited by this paper
• Generation of fibrinolytic activity by infusion of activated protein C into dogs.

  1981cited by this paper
• Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells.

  1981cited by this paper
• Purification and properties of human coagulation factor VII.

  1980cited by this paper
• The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V.

  1979cited by this paper
• Properties of the factor Xa binding site on human platelets.

  1978cited by this paper
• Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

  1978cited by this paper
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

  1976cited by this paper
• Increased sheep lung vascular permeability caused by pseudomonas bacteremia.

  1974cited by this paper
• Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

  1973cited by this paper
• Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

  1973cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Protein C in adult patients with sepsis: from pathophysiology to monitoring and supplementation

  2025cites this paper
• Liver cirrhosis and complications from the perspective of dysbiosis

  2024cites this paper
• Research Progress on Portal Vein Thrombosis in Liver Cirrhosis

  2024cites this paper
• Inflammatory stimuli induce shedding of heparan sulfate from arterial but not venous porcine endothelial cells leading to differential proinflammatory and procoagulant responses

  2023cites this paper
• Coagulofibrinolytic effects of recombinant soluble thrombomodulin in prolonged porcine cardiac arrest

  2023cites this paper
• No Differences in Rotational Thromboelastometry Measurements between Portal and Peripheral Circulation in Cirrhotic Patients Undergoing TIPS

  2023cites this paper
• Application of Nanotechnology in Thrombus Therapy

  2022cites this paper
• Use of Anticoagulants in COVID-19: A Review

  2022cites this paper
• Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis

  2021cites this paper
• Bacterial lipopolysaccharide is associated with stroke

  2021cites this paper
• Gut microbiota and their metabolites in cardiovascular disease.

  2021cites this paper
• Plasma levels of extracellular vesicles and the risk of post-operative pulmonary embolism in patients with primary brain tumors: a prospective study

  2021cites this paper
• Identification of soluble thrombomodulin and tissue plasminogen activator-inhibitor complex as biomarkers for prognosis and early evaluation of septic shock and sepsis-induced disseminated intravascular coagulation.

  2021cites this paper
• Diagnosis and Management of Pediatric Venous Thromboembolism

  2021cites this paper
• Physicochemical Properties and In Vitro Biocompatibility of Three Bacterial Nanocellulose Conduits for Blood Vessel Applications.

  2020cites this paper
• LPS-induced inflammation disorders bone modeling and remodeling by inhibiting angiogenesis and disordering osteogenesis in chickens

  2020cites this paper
• Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation

  2019cites this paper
• Shared risk factors for arterial cardiovascular diseases and venous thromboembolism

  2019cites this paper
• Expression and Purification of Hybrid LL-37Tα1 Peptide in Pichia pastoris and Evaluation of Its Immunomodulatory and Anti-inflammatory Activities by LPS Neutralization

  2019cites this paper
• Deep Vein Thrombosis 2 Antiphospholiped syndrome Dyslipoproteinaemia Nephrotic syndrome Paroxysmal nocturnal haemoglobinuria Myeloproliferative diseases

  2018cites this paper
• Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies

  2018cites this paper
• Distinct from Known Ligands

  2018cites this paper
• Genistein has the function of alleviating and treating disseminated intravascular coagulation caused by lipopolysaccharide

  2018cites this paper
• The Molecular Pathophysiology of Sepsis-Associated Disseminated Intravascular Coagulation and Its Pharmacologic Modulation

  2018cites this paper
• Tissue factor-bearing microparticles and inflammation : a potential mechanism for the development of VTE in cancer

  2018cites this paper
• Spatial structure of lipopolysaccharides and its role in blood coagulation

  2017cites this paper
• Tissue factor‐bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer

  2017cites this paper
• Tissue Factor and Hemostasis

  2017cites this paper
• Deep Vein Thrombosis 2 Antiphospholiped syndrome Dyslipoproteinaemia Nephrotic syndrome Paroxysmal nocturnal haemoglobinuria Myeloproliferative diseases Behçet ’ s syndrome Varicose veins Superficial vein thrombosis Congenital venous malformation Long-distance travel Prolonged bed rest

  2017cites this paper
• Decreased Expression of Thrombomodulin in Endothelial Cells by Fibroblast Growth Factor‐23/α‐Klotho

  2017cites this paper
• Endothelial cells: source, barrier, and target of defensive mediators

  2016cites this paper
• Human Host Defense Cathelicidin Peptide LL-37 Enhances the Lipopolysaccharide Uptake by Liver Sinusoidal Endothelial Cells without Cell Activation

  2016cites this paper
• Gene Variations in the Protein C and Fibrinolytic Pathway: Relevance for Severity and Outcome in Pediatric Sepsis

  2016cites this paper
• The ApoM/S1P-complex: its role in vascular inflammatory disease and interaction with S1P-receptors

  2016cites this paper
• Melatonin does not affect disseminated intravascular coagulation but diminishes decreases in platelet count during subacute endotoxaemia in rats.

  2016cites this paper
• Endotoxemia as a trigger of thrombosis in cirrhosis

  2016cites this paper
• without Cell Activation Uptake by Liver Sinusoidal Endothelial Cells LL-37 Enhances the Lipopolysaccharide Human Host Defense Cathelicidin Peptide

  2016cites this paper
• Untersuchungen zum Einfluss von Melatonin, Citalopram und Sarpogrelate auf die Hämostase in der sub-akuten Endotoxinämie in männlichen Wistar-Ratten

  2015influential citation
• Cancer and venous thromboembolism

  2015cites this paper
• Coagulopathy in liver disease: Lack of an assessment tool.

  2015cites this paper
• The Potential Role of Hemopexin and Heme Oxygenase-1 Inducer in a Model of Sepsis

  2015cites this paper
• Hämostase, Hämotherapie und Lyse

  2015cites this paper
• Portal Vein Thrombosis in Patients with Cirrhosis—Etiology, Diagnosis, and Management

  2015cites this paper
• Elevated venous thromboembolism risk in preeclampsia: molecular mechanisms and clinical impact.

  2015cites this paper
• Thrombomodulin--a new target for treating stroke at the crossroad of coagulation and inflammation.

  2014cites this paper
• Study of the thrombogenicity induced by the cytotoxic treatment of malignant disease

  2014cites this paper
• Pulmonary Vascular Physiology and Pathophysiology

  2014cites this paper
• Microparticles: new light shed on the understanding of venous thromboembolism

  2014cites this paper
• Decreased thrombomodulin mRNA expression on peripheral monocytes in disseminated intravascular coagulation patients relates to poor outcomes: the ex vivo effects of lipopolysaccharide and thrombin on monocyte thrombomodulin and CD14 mRNA.

  2013cites this paper
• Clotting Activation and Hyperfibrinolysis in Cirrhosis: Implication for Bleeding and Thrombosis

  2013cites this paper
• Physiological Importance of Endothelium

  2013cites this paper
• Lésions endothéliales liées à un défaut de contrôle du complément : de la génétique du complément au syndrome hémolytique et urémique

  2013cites this paper
• Family of CD93 and Recently Discovered Groups of CTLDs

  2012cites this paper
• Inflection points in sepsis biology: from local defense to systemic organ injury.

  2012cites this paper
• Relationship Between the Inflammation and Coagulation Pathways in Patients with Severe Sepsis

  2012cites this paper
• Viscoelastic and aggregometric point‐of‐care testing in patients with septic shock – cross‐links between inflammation and haemostasis

  2012cites this paper
• Risk Factors of Deep Vein Thrombosis

  2012cites this paper
• New insights into the mechanisms of venous thrombosis.

  2012cites this paper
• Mechanisms of Thrombosis in Paraproteinemias: The Effects of Immunomodulatory Drugs

  2012cites this paper
• Design, Fabrication, Characterization and Modeling of Integrated Functional Materials

  2012cites this paper
• 1 Risk Factors of Deep Vein Thrombosis

  2012cites this paper
• Update on disseminated intravascular coagulation: when to consider it, when to expect it, when to treat it.

  2012cites this paper
• Thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation

  2011cites this paper
• Individualised Heparin and Protamine Sulfate Management in Infants Undergoing Cardiac Surgery with Cardiopulmonary Bypass

  2011cites this paper
• Effect of a prostaglandin I2 analog on the expression of thrombomodulin in liver and spleen endothelial cells after an extensive hepatectomy

  2011cites this paper
• cells and Madin-Darby canine kidney epithelial cells Opposite sorting of tissue factor in human umbilical vein endothelial

  2011cites this paper
• Activated protein C modulates inflammation, apoptosis and tissue factor procoagulant activity by regulating endoplasmic reticulum calcium depletion in blood monocytes

  2011cites this paper
• cells in response to bacterial endotoxin Hemoglobin enhances the production of tissue factor by endothelial

  2011cites this paper
• Effect of antimicrobial cathelicidin peptides on the endothelial cell apoptosis

  2011cites this paper
• Modulation of Hemostatic Pathways by Breast Cancer Chemotherapy Agents

  2011cites this paper
• Inflammation and the development of atherosclerosis.

  2011cites this paper
• Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells.

  2011cites this paper
• Assessment of the Effect of Induced Hypothermia in Experimental Sepsis Using a Cecal Ligation and Perforation Mouse Model

  2011cites this paper
• The endothelium: physiological functions and role in microcirculatory failure during severe sepsis

  2010cites this paper
• Fundamentals of Inflammation

  2010cites this paper
• Gerinnung bei schwerer Sepsis unter besonderer Berücksichtigung der Monozyten

  2010cites this paper
• Cellular regulation of blood coagulation: a model for venous stasis.

  2010cites this paper
• The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

  2010cites this paper
• Einfluss einer perioperativen Omega-3-Fettsäure Infusion auf die hämodynamische Funktion bei kardiochirurgischen Bypasspatienten

  2009cites this paper
• Shiga Toxin and Lipopolysaccharide Induce Platelet-Leukocyte Aggregates and Tissue Factor Release, a Thrombotic Mechanism in Hemolytic Uremic Syndrome

  2009cites this paper
• New Concepts and Emerging Issues in Sepsis

  2009cites this paper
• Systemic inflammatory response following acute traumatic brain injury.

  2009cites this paper
• Pigs transgenic for human thrombomodulin have elevated production of activated protein C

  2009cites this paper
• Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study

  2009cites this paper
• Markers of vascular endothelial cell damage and P. falciparum malaria: association between levels of both sE-selectin and thrombomodulin, and cytokines, hemoglobin and clinical presentation.

  2008cites this paper
• Cellular Encapsulation Techniques: Camouflaging Islet Cells from the Immune and Inflammatory Responses Associated with Islet Transplantation

  2008cites this paper
• L’endothélium : un nouvel organe

  2008cites this paper
• Ostéonécrose expérimentale induite par l’association de lipopolysaccharide à faible dose et de méthylprednisolone à forte dose chez le lapin

  2008cites this paper
• ’ endothélium : un nouvel organe he endothelium : A new organ

  2008cites this paper
• The development of hyaluronic acid biomaterials for vascular tissue engineering

  2008cites this paper
• RNA-binding protein HuR interacts with thrombomodulin 5 ’ UTR and represses IRES-mediated translation under IL-1 treatment

  2008cites this paper
• The Yin–Yang of thrombin and activated protein C

  2008cites this paper
• Abstoßungsdiagnostik bei heterotoper und orthotoper Xenotransplantation von hDAF-transgenen Schweineherzen im Primatenmodell mit perioperativer Immunadsorption

  2008cites this paper
• Inactivation of Thrombomodulin by Ionizing Radiation in a Cell-Free System: Possible Implications for Radiation Responses in Vascular Endothelium

  2008cites this paper
• Changes in serum interleukin-6, C-reactive protein and thrombomodulin levels under periodontal ultrasonic debridement.

  2008cites this paper
• Hyaluronic acid cues for functional endothelialization of vascular constructs

  2008cites this paper
• RNA-binding protein HuR interacts with thrombomodulin 5'untranslated region and represses internal ribosome entry site-mediated translation under IL-1 beta treatment.

  2008cites this paper
• Influence of obesity on sepsis.

  2008cites this paper
• Thrombin downregulates thrombomodulin expression and activity in primary human endothelial cells.

  2008cites this paper
• Inhibiteurs de la coagulation et états infectieux graves Coagulation inhibitors and severe sepsis: State of the art

  2008cites this paper